Research Article

Identification of Bexarotene as a PPAR Antagonist with HDX

Figure 3

Biochemical characterization of Bexarotene on PPARγ: (a) TR-FRET competitive displacement assay (). (b) Dose dependent transcriptional activity of a PPARγ:PPRE-luciferase promoter-reporter assay in HEK293T cells (). (c) Dose dependent transcriptional activity of rosiglitazone ±1 μM Bexarotene in a PPARγ:PPRE-luciferase promoter-reporter assay in HEK293T cells ().
(a)
(b)
(c)